http://www.fda.gov/cder/orange/appendix_a.txt 3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
http://www.fda.gov/cder/dmf/text/4Q2003NEWTEXT.txt CHINA." 16892 V 3-Sep-2003 ALTHEA TECHNOLOGIES INC "ASEPTIC FORMULATION, FILL, AND FINISH FACILITY IN SAN DIEGO, CA." 16893 III 15-Sep-2003 ERIE MOLDED PLASTICS INC "LID FOR DEODORANT AS MANUFACTURED IN ERIE, PA." 16894 II 5-Oct-2003 DIVIS LABORATORIES LTD "LEVITERACETAM AS MANUFACTURED IN ANDHRA PRADESH, INDIA." 16895 IV 6-Oct-2003 FIRMENICH INC "NATURAL & ARTIFICIAL ORANGE FLAVOR...
http://www.fda.gov/cder/dmf/xls/4Q2003NEWEXCEL.xls II RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA SERTRALINE HYDROCHLORIDE FORM II AS MANUFACTURED IN CAMPOVERDE DI APRILIA (LT), ITALYHYDROCHLORIDE AS MANUFACTURED IN ANDHRA PRADESH, INDIA II NICHOLAS PIRAMAL INDIA LTD ITRACONAZOLE AS MANUFACTURED IN ANDHRA...
Efficacy Supplements Approved in Calendar Year 1998 ANAGRELIDE HYDROCHLORIDE ROBERTS LABS 20-333 02-Jan-98 16-Dec-98 SE1 11.4 Treatment of patients with thrombocythemia, secondary to myeloproliferative disorders, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic eventsHYDROCHLORIDE BIOVAIL LABS 20-401 30-Jan-97 30-Jan-98...
author: Brenda Harmon
PRESCRIPTION DRUG PRODUCT LIST 17TH EDITION RX DRUG PRODUCT LIST Prescription and Over-the-Counter Drug Product List - 17th Edition Cumulative Supplement Number 3: Feb '97 - Mar '97 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST - - ADD - AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; - ADD - AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; - ADD - POTASSIUM PHOSPHATE, DIBASIC; SODIUM...
FDA Drug Approvals List Drug Approvals for March 1997 Definitions and Notes March 1997 Original New Drug Applications Original Application #: 020570 Approval Date: 28-MAR-97 Trade Name: QUADRAMET Chemical Type: 1 Therapeutic Potential: S Dosage Form: INJECTABLE Applicant: CYTOGEN CORP Active Ingredient(s): SAMARIUM SM 153 EDTMP OTC/RX Status: RX Indication(s): For relief of pain in patients with confirmed...
Drug Approvals January 1997 Drug Approvals for January 1997 Definitions and Notes January 1997 Original New Drug Applications Original Application #: 050733 Approval Date: 30-JAN-97 Trade Name: ZITHROMAX Chemical Type: 3 Therapeutic Potential: S Dosage Form: INJECTABLE Applicant: PFIZER INC Active Ingredient(s): AZITHROMYCIN OTC/RX Status: RX Indication(s): Treatment of patients with community-acquired...
FDA Drug Approvals List March 2000 Original Application #: 021124 Approval Date: 17-MAR-00 Trade Name: LAMISIL Chemical Type: 6 Therapeutic Potential: S Dosage Form: SOLUTION Applicant: NOVARTIS PHARMACEUTICALS CORP DBA SANDOZ PHARMACEUTICALS CORP Active Ingredient(s): TERBINAFINE HYDROCHLORIDE OTC/RX Status: RX Indication(s): For the treatment of interdigital-type pedis (athlete’s foot), tinea cruris (jock...
COMP Press Release 9th meeting Press Release The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. (44- 20) 74 18 84 00 Fax (44- 20) 74 18 86 13 E- mail: mail@ emea. eudra. org http:// www. eudra. org/ emea. html 18 January 2001 COMP/ 16/ 01 corr. ...
author: COMP
subject: Press Release
COMP Press Release 9th meeting page 3 Press Release COMP/ 16/ 01 3/ 6 ANNEX I to COMP January 2001 Press Release Medicinal products Designated as Orphan Medicinal Products since the December 2000 Press Release Active substance Thalidomide Sponsor Laboratoires Laphal Orphan Indication Treatment of Erythema nodosum leprosum (ENL) or type II lepra ...
author: COMP
subject: Press Release
Index A, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - INDEX - Index-A-~ Index-B -~ Index-C -~ Index-D -~ Index-E -~ Index-F -~ Index-G -~ Index-H -~ Index-I -~ Index-J -~ Index-K -~ Index-L -~ Index-M -~ Index-N -~ Index-O ...
Index: AN: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
THE MERCK MANUAL OF GERIATRICS, Index A vascular dementia 363 Amantadine 1377t in influenza 770 in parkinsonism 438t , 439 Amaurosis fugax 1307-1308 in carotid artery atherosclerosis 403 in giant cell arteritis 508 Ambulation exercises 273 , 274f after stroke 281-282 Amebic abscess 1130 American Society of Anesthesiologists, Physical Status Classification of, 244 , 244t Amifostine 719 Amikacin 1367t Amiloride in...
Cedra Corp. Methods List April 2004.xls CEDRA's List of GLP Validated, Pharmaceutical Bioanalytical Methods Drug Species AntiCoagulant Matrix Extraction Volume Range Abacavir* Human Plasma 0.05 mL 25 – 5000 ng/ mL Acetaminophen* Human Heparin Plasma 0.2 mL 0.25 – 25 µg/ mL Acetaminophen* Human Heparin Plasma 0.25 mL 0.15 – 15 µg/ mL Acetaminophen* 0.15 – 15 µg/ mL Propoxyphene* 1 –...
author: Information Systems
Cedra Corp. Methods List April 2004.xls page 1
author: Information Systems
Approved Active Moieties to which FDA has issued a Written Request for Pediatric Studies under Section 505A of the Federal Approved Active Moieties to which FDA has issued a Written Request for Pediatric Studies under Section 505A of the Federal Food, Drug, and Cosmetic Act NOTE: This list simply identifies approved active moieties to which FDA has issued a Written Request for pediatric studies since June 1998
THE MERCK MANUAL OF GERIATRICS, Index A vascular dementia 363 Amantadine 1377t in influenza 770 in parkinsonism 438t , 439 < DT>Amaurosis fugax 1307-1308 in carotid artery atherosclerosis 403 in giant cell arteritis 508 Ambulation exercises 273 , 274f after stroke 281-282 Amebic abscess 1130 American Society of Anesthesiologists, Physical Status Classification of, 244 , 244t Amifostine 719 Amikacin 1367t Amiloride 839t...
Cedra Corp. Methods List January 2004.xls page 1
author: Information Systems
Cedra Corp. Methods List January 2004.xls CEDRA's List of GLP Validated, Pharmaceutical Bioanalytical Methods Drug Species AntiCoagulant Matrix Method Range Abacavir* Human Plasma LC- MS- MS 25 – 5000 ng/ mL Acetaminophen* Human Heparin Plasma HPLC 0.25 – 25 µg/ mL Acetaminophen* Human Heparin Plasma LC- MS- MS 0.15 – 15 µg/ mL Acetaminophen* 0.15 – 15 µg/ mL Propoxyphene* 1 – 150 ng/...
author: Information Systems
http://www.adis.com/files/newsletters/CT/Ctcov60.pdf 4 Elderly with breast cancer being denied treatment 4 Pharmacology Pemetrexed: less toxicity spells savings in NSCLC 3 Cytarabine + liposomal daunorubicin in leukaemia 9 Trastuzumab unavailable despite NICE guidelines 2 Daunorubicin (liposomal) + cytarabine in leukaemia 9 Therapy Pharmacoeconomics Anastrozole vs letrozole in breast cancer 7 Antineoplastics and mucositis: clinical,...
http://www.adis.com/files/newsletters/REA/Rxcov978.pdf 2 Ganciclovir: skin rash and splinter haemorrhages [ ] 12 Challenges and essentials in pharmacovigilance of herbal 3 Gemcitabine: fatal liver failure [S] 13 medicines Gemcitabine: Stevens- Johnson syndrome/ toxic epidermal 13 Health Canada warns against use of Stamen and Bell Magicc 2 necrolysis [S] Bullet Glipizide: fatal liver failure [ S] 13 UMC and IMS Health collaborate on WHO...
http://www.adis.com/files/newsletters/REA/Rxcov977.pdf 20 Ergotamine: interaction with concomitant ritonavir leading to 10 Current Issues & Opinions ergotism and coma [X S] Pemetrexed: less toxicity spells savings in NSCLC 2 Fenyramidol: hepatotoxicity [ ] 10 Fewer drugs withdrawn for safety reasons in Canada than US 3 Flecainide: cardiotoxicity following in utero treatment [S] 11 Adverse Reaction Research Flecainide: fatal ventricular...
Reference Listed Drug Labeling Approved in March 2000 TRADENAME ACTIVE/DOSAGE FORM NDA# SUPP# FIRM MAR DIOVAN HCT Valsartan/HCTZ/tab 20-818 S-006 Novartis Pharms 1 TIMOPTIC in OCCUDOSE Timolol maleate/opth.sol 19-463 S-020 Merck 2 EFFEXOR Venlafaxine HCl 20-151 S-014 Wyeth Ayerst 3 EFFEXOR XR Venlafaxine HCl 20-699 S-008 Wyeth Ayerst 3 TECZEM Diltiazem malate/enalapril maleate 20-507 S-002 Aventis Pharms 3 PROPULSID Cisapride/oral sol...
author: USERNAME
Shire Pharmaceuticals plc - Biotech Analytics Click above for profile 30th December 2002 – Shire Pharmaceuticals Plc – sale of Over The Counter Products Portfolio to Purdue Shire Pharmaceuticals Group plc announces that it has sold its US Over The ...
Cancer symptoms treatments - Dana-Farber Cancer Institute Learn about cancer symptoms, treatments, detection, screening, cancer types, trials and causes at Dana-Farber. Find the cancer information on all types of cancer at the Dana-Cancer web site. ...
